Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Mild Cognitive Impairment (MCI) or mild Alzheimer's disease.
- People who have test results (such as a brain scan or fluid sample from around the spine) showing signs of amyloid protein buildup in the brain, which is associated with Alzheimer's disease.
- People who have already had a brain imaging scan performed.
- People who scored higher than 24 on a standard memory and thinking test called the Mini Mental Status Examination (MMSE).
- People who have a Clinical Dementia Rating (CDR) score of 0.5 to 1, which indicates very mild to mild impairment (confirm with trial site).
- People who have been taking memory-related medications (cholinesterase inhibitors and/or memantine) at the same dose for at least one month.
- People who are between 40 and 90 years of age.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a type of dementia other than Alzheimer's disease, such as Lewy body dementia, frontotemporal dementia, vascular dementia, or Jakob-Creutzfeldt disease, among others.
- People who are unable to tolerate a specific type of brain scan called a resting state functional MRI (rs-fMRI).
- People who have implants or metal in their body that make it unsafe to have an MRI scan.
- People who have a seizure disorder (epilepsy or a history of seizures).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of TBS on cognition between and within subjects using Repeatable Battery for the Assessment of Neuropsychological Status Update (RBANS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.